Form D · Pharmaceuticals
Ternus Pharma, Inc.
Duxbury, MA · CIK 0001688608
Offering snapshot reported Nov 10, 2016 · SEC filing
- Reported sold
- $185K Offering amount: $1M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 31, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2016 | Initial | $185,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-274209
Source: Form D, filed Nov 10, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc R. Cote | Director, Executive |
| Sundeep Dugar | Director, Executive |
| William D. Kerns | Director, Executive |
| Dhiren Thakker | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
130 Tobey Garden Street
Duxbury, MA, 02332
Duxbury, MA, 02332